SCHEMBL30690339

SCHEMBL30690339

CCCCCCCCCCCCCC(=O)CC(=O)CCC

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HAO1 Q9UJM8 1/20 0.65
KMT2A Q03164 2/20 0.60
MAPT P10636 1/20 0.60
CES2 O00748 4/20 0.56
CES1 P23141 4/20 0.56
GPR84 Q9NQS5 7/20 0.54
PPARG P37231 7/20 0.54
PPARD Q03181 7/20 0.54
PPARA Q07869 7/20 0.54
HDAC11 Q96DB2 5/20 0.54
TSHR P16473 4/20 0.54
PTPN1 P18031 3/20 0.54
ALDH1A1 P00352 2/20 0.54
TLR2 O60603 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
FABP4 P15090 2/20 0.54
SLC22A6 Q4U2R8 1/20 0.54
SLC22A8 Q8TCC7 1/20 0.54
MEN1 O00255 1/20 0.54
ESR1 P03372 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13860365 1.00 HAO1 (0.65) HAO1KMT2AMAPTCES2CES1
SCHEMBL5216311 1.00 HAO1 (0.65) HAO1KMT2AMAPTCES2CES1
SCHEMBL11256120 1.00 HAO1 (0.65) HAO1KMT2AMAPTCES2CES1
SCHEMBL21552126 1.00 HAO1 (0.65) HAO1KMT2AMAPTCES2CES1
SCHEMBL5273375 0.97 HAO1 (0.61) HAO1KMT2AMAPTCES2CES1
SCHEMBL23437862 0.95 HAO1 (0.71) HAO1KMT2AMAPTCES2CES1
SCHEMBL3051705 0.95 HAO1 (0.71) HAO1KMT2AMAPTCES2CES1
SCHEMBL7760601 0.95 HAO1 (0.71) HAO1KMT2AMAPTCES2CES1
SCHEMBL15941224 0.95 HAO1 (0.71) HAO1KMT2AMAPTCES2CES1
SCHEMBL11673647 0.95 HAO1 (0.71) HAO1KMT2AMAPTCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023250513-A1 13-MEMBERED MACROLIDE COMPOUNDS FOR TREATING DISEASES MEDIATED BY ABNORMAL PROTEIN TRANSLATION ZIKANI THERAPEUTICS, INC. (US) 2023-12-28 WO disclosed